First drug to develop new teeth to be tested on humans

Katsu Takahashi, an advanced researcher in the field of dentistry, has been tirelessly dedicated to innovative research to develop drugs that stimulate the tooth growth.

His search for an effective and revolutionary solution for the growth of new teeth has aroused great interest in the scientific community and the dental industry.

Takahashi and his team have focused on understanding the biological processes involved in the natural growth of teethin order to develop an accurate and safe therapeutic approach.

Through years of study and experimentation, they have carefully explored the cell signaling pathways and growth factors that play a key role in the formation of these structures.

Study shows promising results and drug will be tested on humans

Image: iLexx – Envato Elements/Reproduction

After dedicating themselves entirely to research that began in 2005, scientists developed a medicine composed of monoclonal antibodies. This is the first medicine for growing new teeth that will be tested in humans.

Animal tests have yielded promising results and now the next step is to analyze the effectiveness of the medicine in human organisms.

The study’s lead researcher and member of Kyoto University in Japan told the newspaper The Mainichi that “the idea of ​​growing new teeth is every dentist’s dream.”

The drug will be aimed at people suffering from anodontia, a rare condition characterized by the complete congenital absence of permanent teeth. It differs from dental agenesis, where some permanent teeth do not develop.

In anodontia, permanent teeth do not form, resulting in total absence of teeth adults. Testing is expected to begin in July 2024 and, if everything meets the necessary standards, the drug should hit the market in 2030.

The results of the medicine will be monitored by scientists, who have already tested the compound on volunteers. The first approved medicine should be intended for children aged 2 to 6.